Develops alcohol-free sanitizing solutions. Produces sanitizers for personal use. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
An average decline of 54% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
This company is not turning a profit, so the market is pricing its sales instead: 4.3× for every dollar of annual revenue.
No analyst target is on record for this company.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Our checks did not surface a specific strength to highlight here.
A loss of $252K against $12K in annual sales. And on top of that, sales fell from the year before.
The stock sits at $0.0002. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.